NKF News

NKF DocWire News / Apr 21, 2021

NKF 2021 Spring Clinical Meetings The pandemic of COVID-19 has had a negative impact on various organ systems and on individuals of all ages. Kidney involvement in patients with COVID-19 typically manifested as acute kidney injury (AKI). However, there are few consensus data on the epidemiology of AKI in COVID-19.

NKF TAPinto.net / Apr 21, 2021

MARLTON, NJ - A Burlington County man and his family are asking for the public's help to save his life. Mark Klayman, who lives in Marlton, is in desperate need to find a kidney donor - and time is literally running out. Mark, who was diagnosed in 2009 with kidney cancer, has Stage 4 Kidney Disease.

NKF WNEP Scranton/Wilkes-Barre / Apr 17, 2021

Cecelia Chmiola of Mountain Top and Donna Tovalin of Cypress, Texas share a bond that goes far beyond being siblings. Living 1,500 miles away from each other, sisters Cecelia Chmiola of Mountain Top and Donna Tovalin of Cypress, Texas, share a bond that goes far beyond being siblings.

NKF Pacific Business News (Honolulu) / Apr 17, 2021

The City and County of Honolulu has extended free Covid-19 testing to all Oahu hotel workers. The program launched Thursday through a partnership with the National Kidney Foundation of Hawaii Consortium, which operates the mobile lab at the Daniel K. Inouye International Airport, along with a testing facility at the Hawaiian Monarch Hotel in Waikiki.

NKF DocWire News / Apr 16, 2021

NKF 2021 Spring Clinical Meetings One part of clinical decision making focuses on an understanding of patient and physician preferences regarding various types of treatment. There are few data available examining the value patients and physicians place on specific treatment attributes in anemia in chronic kidney disease.

NKF WNEP Scranton/Wilkes-Barre / Apr 16, 2021

Cecelia Chmiola of Mountain Top and Donna Tovalin of Cypress, Texas share a bond that goes far beyond being siblings. Living 1,500 miles away from each other, sisters Cecelia Chmiola of Mountain Top and Donna Tovalin of Cypress, Texas, share a bond that goes far beyond being siblings.

NKF Renal and Urology News / Apr 16, 2021

Voclosporin improves the likelihood of complete renal response in patients with lupus nephritis (LN) of any biopsy class, investigators reported in a poster presentation at the virtual 2021 National Kidney Foundation Spring Clinical meetings.

NKF HealthDay News / Apr 16, 2021

FRIDAY, April 16, 2021 (HealthDay News) -- Dialysis is time-consuming, making it hard for kidney failure patients to keep fit. But cycling during treatment sessions could boost patients' heart health and cut medical costs, new research shows.Dialysis can lead to long-term scarring of the heart, whic...

NKF DocWire News / Apr 15, 2021

NKF 2021 Spring Clinical Meetings Daniel Coyne, MD, and colleagues reported pooled results from roxadustat phase 3 studies vis-à-vis the rates of red blood cell transfusion and volume-related adverse events post-transfusion among non-dialysis-dependent chronic kidney disease (NDD-CKD) patients enrolled in studies of roxadustat versus placebo. The pooled results were reported during a virtual poster session...

NKF DocWire News / Apr 14, 2021

NKF 2021 Spring Clinical Meetings The strongest independent predictor of mortality in patients on hemodialysis is pre-dialysis hyperkalemia.1,2 To help inform clinical practice, researchers at AstraZeneca (Wilmington, Delaware, United States) conducted a study to update estimates of the prevalence of pre-dialysis hyperkalemia and the patient characteristics associated with higher hyperkalemia prevalence.

NKF Renal and Urology News / Apr 13, 2021

Women have less access to the kidney transplant waitlist, investigators revealed at the virtual National Kidney Foundation 2021 Spring Clinical Meetings. According to the United States Renal Data System, 19.4% of the 1,337,386 patients receiving dialysis during 2005 to 2016 were placed on the waitlist for a deceased donor kidney transplant.

NKF DocWire News / Apr 13, 2021

NKF 2021 Spring Clinical Meetings Hyperkalemia, a potentially life-threatening condition, can lead to paralysis and cardiac arrhythmias. At present, there are three potassium binders marketed in the United States for the treatment of hyperkalemia: sodium polystyrene sulfonate (SPS), patiromer, and sodium zirconium cyclosilicate (SZC). There are few data available on the use of these binders...

NKF MedPage Today / Apr 12, 2021

The potassium binder patiromer (Veltassa) was deemed safe and well-tolerated in patients with hyperkalemia, post-marketing data showed. Since its approval in October 2015, real-world data from the past 4 years found the sodium-free drug had a similar safety profile as it did in the clinical trials, reported Matthew Weir, MD, of the University of Maryland School of Medicine in Baltimore, in a poster at the virtual National Kidney Foundation Spring Clinical meeting.

NKF Healio / Apr 10, 2021

Members of a joint task force established by the American Society of Nephrology and National Kidney Foundation presented an interim report on the removal of race as a factor in estimating GFR for patients with kidney disease.“Why don’t we just think it terms of dropping race” when estimating GFR, Cynthia Delgado, MD, an associate clinical professor of medicine at the VA Medical